Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Lung cancer screening sites test best ways to help smokers quit

NCT ID NCT03315910

Disease control Sponsor: Memorial Sloan Kettering Cancer Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at which treatments work best to help smokers reduce or quit smoking when they come for lung cancer screening. About 800 patients at lung cancer screening sites across the U.S. are taking part. The goal is to find a simple, effective approach that screening sites can use without overloading their staff.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

807 people

The number who actually took part.

Started

Oct 2017

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 to 80 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Site Eligibility (as per SC self-report) \& Must be designated as an American College of Radiology (ACR) designated lung cancer screening site * Reports at least one year of lung cancer screening experience * Reports conducting at least 20 new initial screenings per month Site Coordinator (SC) Eligibility (as per SC self-report) * Employed as a full-time Site Coordinator at participating lung cancer screening site Patient Eligibility (as per self-report) * Between the ages of 50-80 years old * Seeking baseline or annual follow-up LDCT lung cancer screening * Have at least a 20 pack-year history of smoking * Currently a smoker, defined as self-reported cigarette smoking (some days, every day) within the past 30 days. * Must be reachable by telephone * Must be English or Spanish speaking due to the study materials being available in only these languages and limited available resources for translation. Exclusion Criteria: Patient (as per self-report) * NRT is medically contraindicated (e.g., recent heart attack within the last 2 weeks or, unstable/worsening angina). * Smokers who are receiving other tobacco treatment services or have used cessation medications (NRT, bupropion, varenicline) within the past month.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Smoking cessation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Smoking Cessation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Smoking cessation

Contacts and locations

Locations

  • Carolinas Healthcare System Blue Ridge

    Morganton, North Carolina, 28655, United States

  • Fairfield Medical Center

    Lancaster, Ohio, 43130, United States

  • Henry Ford Hospital (Data collection only)

    Detroit, Michigan, 48202, United States

  • John Muir Health

    Walnut Creek, California, 94598, United States

  • Legacy Health

    Portland, Oregon, 97210, United States

  • Maine Medical Center Cancer Institute

    Scarborough, Maine, 04074, United States

  • Memorial Sloan Kettering Cancer Center

    New York, New York, 10065, United States

  • MercyOne Des Moines Medical Center (Data Collection Only)

    Des Moines, Iowa, 50314, United States

  • Montefiore Medical Center (Data Collection Only)

    The Bronx, New York, 10467, United States

  • Munson Healthcare

    Traverse City, Michigan, 49684, United States

  • NYU Winthrop Hospital

    Mineola, New York, 11501, United States

  • Riverside Healthcare

    Kankakee, Illinois, 60901, United States

  • Rush University Medical Center

    Chicago, Illinois, 606012, United States

  • St. Mary Medical Center, Community Healthcare System

    Crown Point, Indiana, 46307, United States

  • Temple University

    Philadelphia, Pennsylvania, 19140, United States

  • University of Southern California (Data Collection Only)

    Los Angeles, California, 90033, United States

  • Weill Cornell Medical Center

    New York, New York, 10065, United States

  • WellStar Health System

    La Grange, Georgia, 30240, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.